SCHEMBL1015956

SCHEMBL1015956

Cc1ccc(-c2ccoc2)cc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 4/20 0.43
CYP3A4 P08684 3/20 0.43
TSHR P16473 3/20 0.43
CASP1 P29466 1/20 0.43
HDAC2 Q92769 1/20 0.42
ERN1 O75460 1/20 0.41
CHEK1 O14757 2/20 0.40
RAB9A P51151 3/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6866139 0.81 CYP3A4 (0.62) ALDH1A1KDM4ESMN1; SMN2TDP1CYP3A4
SCHEMBL31661348 0.81 CYP3A4 (0.62) ALDH1A1KDM4ESMN1; SMN2TDP1CYP3A4
SCHEMBL1015776 0.77 ERN1 (0.45) ALDH1A1SMN1; SMN2TDP1CYP3A4TSHR
SCHEMBL20036778 0.77 ERN1 (0.53) ALDH1A1CYP3A4TSHRCASP1ERN1
SCHEMBL19475523 0.77 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4TSHRHDAC2
SCHEMBL7461800 0.76 CYP3A4 (0.41) ALDH1A1TDP1CYP3A4TSHRCASP1
SCHEMBL438139 0.74 TDP1 (0.70) ALDH1A1KDM4ESMN1; SMN2TDP1CYP3A4
SCHEMBL13862442 0.74 ALDH1A1 (0.61) ALDH1A1KDM4ESMN1; SMN2TDP1CYP3A4
SCHEMBL3135893 0.73 ALOX15 (0.65) ALDH1A1KDM4ETDP1CYP3A4HDAC2
SCHEMBL12121819 0.73 ERN1 (0.61) ALDH1A1CYP3A4TSHRHDAC2ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885KDM4E 4108/4885SMN1; SMN2 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.